stock & financial message boards
  Login  |  Register |  Site Map  |  Blogs |  Recent Activity  |  Members  | Glossary
Ticker/Industry
  Joined Today: 0

« Previous | Next » | All Messages |  GTHA Message Board Home | recommend post |  Ignore Poster

Message #19
From: Stock News Bot
Date: December 14, 2006 01:05:00 PM

GTHA News GeneThera Announces Preliminary Agreement with Mexican University for Collaborative Work on Johne's Disease and Vaccination

WHEAT RIDGE, Colo.--(BUSINESS WIRE)--GeneThera (OTCBB:GTHA) announces that it has progressed with negotiations with a leading Mexican University to develop a test and vaccine for Johne’s Disease.

Commenting on the talks between the parties, Dr. Tony Milici, CEO of GeneThera said, “Our relationship going forward with the Universidad National Autonoma de Mexico (National Autonomous University of Mexico) is very exciting. This is the largest University in Mexico with a very modern research facility. We are entering into an agreement to develop a Johne’s test and vaccine working at their facility. Johne’s is a huge problem in Mexico and the resultant loss in cattle production hurts the Mexican economy to a large degree. Our goal is to work with UNAM and their research scientists to come up with a nationwide testing and vaccination program that will eventually eradicate Johne’s Disease in Mexico.”

Dr. Chaves Gris, Director of the Department of Animal Pathology at UNAM and head of the Johne’s program in Mexico said, “We are very happy that GeneThera was introduced to us and are optimistic that they and our people can come up with a fast and accurate test for Johne’s Disease and an eventual vaccine for this big problem.”

The parties are finalizing the details of the Agreement and will put out a subsequent release when executed.

ABOUT GENETHERA, INC.:

GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GEA™, a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GEA™ is designed for a host of individual diseases, the current priority being Mad Cow Disease, Chronic Wasting Disease, a disease affecting elk and deer in North America; E.Coli 0157:H7 and Johne's Disease, diseases affecting cattle worldwide.

ABOUT UNIVERSIDAD NACIONAL AUTONOMA de MEXICO:

The National Autonomous University of Mexico (Universidad Nacional Autónoma de México, abbreviated as UNAM) was founded in 1551 by Royal Decree signed by Charles V, Holy Roman Emperor at Valladolid, Spain.

It is the largest university in Latin America and is ranked the best in Latin America, Spain and Portugal according to a study conducted by The Times released in 2005-2006. A study by Beijing University also considered UNAM to be the best university in the region and also the sole most important University in the Spanish-speaking world.

It consists of faculties rather than departments. Both undergraduate and graduate studies are available. UNAM is also responsible for the Escuela Nacional Preparatoria (ENP) (National Preparatory School), and the Colegio de Ciencias y Humanidades (CCH), which consist of several high schools, spread around Mexico City. Counting ENEP, CCH, undergraduate and graduate students, UNAM has over 269,000 students, making it one of the world's largest universities.

In addition, it is the only university in Mexico with three Nobel Laureates among its former students: Alfonso García Robles (Peace), Octavio Paz (Literature), and Mario Molina (Chemistry).

Stay up to date with MN1 NewsWire “NEWS YOU CAN TRUST” at www.MN1.com

« Previous | Next » | All Messages |  GTHA Message Board Home | Ignore Poster